$CYTR,,No Reverse Split means they can't offer man
Post# of 22755
Now the question remains, what about the Phase 2b results? This was due out by end of June then pushed back to mid-July and most were hopeful for the news at yesterday's shareholder meeting. Now, from what I read, the news will be out end of July. I am wondering if the CEO and Board elected to withhold the Trial data until after the shareholder meeting so they could do an R/S, get the stock to $5 - $6 level AND THEN come out with trial data.
Even not so good data would keep them above $1 for awhile as they scramble to find a partnership or buyer.
https://twitter.com/twitter/statuses/957208055766241280